 |
|
Researchers discover new risk factor for cardiovascular disease, and a way to control it
November 10, 2008A team of international researchers - including scientists from the McGill University Health Centre (MUHC) and McGill University - have discovered that having high levels of particular protein puts patients at increased risk of developing cardiovascular disease. The results of the study were so conclusive that the clinical trial had to be stopped before its scheduled completion date.
Researchers associated with the international JUPITER Project have demonstrated that high levels of high-sensitivity C-reactive protein (hs-CRP) leads to increased risk of cardiovascular disease. This risk decreases by up to 44% if the patients are treated with statin medications.
Dr. Jacques Genest, of the Research Institute of the MUHC and McGill's Faculty of Medicine led the Canadian component of the JUPITER clinical study, which was initiated by Dr. Paul Ridker of the Harvard University Faculty of Medicine.
"The risk of cardiovascular disease due to increased hs-CRP levels has been greatly underestimated until now," according to Dr Genest. "Our results show that this is an extremely important indicator that doctors will have to consider in the future."
"We hope that this study will prompt a review of current clinical practices, especially in terms of screening and prevention in adults," he added. "However, we still need to do more research to establish specific standards."
The JUPITER study included 17,802 patients from 27 different countries. All had normal levels of cholesterol (LDL-c) and high levels of hs-CRP, and according to current standards, were not considered "at risk" for cardiovascular events, and were therefore not receiving any treatment. During the study, participants received a daily dose of the statin drug rosuvastin, and its consequences were striking: a 44% decrease in the risk of cardiovascular disease and a 21% decrease in mortality.
"These results definitely surpassed our predictions," said Dr. Genest. "We had to stop the study before its scheduled completion, as the benefit of the treatment for the selected patients was so great that we needed to present our findings to the medical community as soon as possible."
Since statins have a cholesterol-lowering effect, they are currently used to prevent cardiovascular disease in patients who are at-risk due to high LDL-c levels. But cardiovascular disease is also caused by vascular inflammation, which is marked by levels of hs-CRP. This study shows that statins indeed act on both cholesterol and inflammation, an effect that has long been suspected but not proven.
McGill University Health Centre
"The risk of cardiovascular disease due to increased hs-CRP levels has been greatly underestimated until now," according to Dr Genest. "Our results show that this is an extremely important indicator that doctors will have to consider in the future."
"We hope that this study will prompt a review of current clinical practices, especially in terms of screening and prevention in adults," he added. "However, we still need to do more research to establish specific standards."
The JUPITER study included 17,802 patients from 27 different countries. All had normal levels of cholesterol (LDL-c) and high levels of hs-CRP, and according to current standards, were not considered "at risk" for cardiovascular events, and were therefore not receiving any treatment. During the study, participants received a daily dose of the statin drug rosuvastin, and its consequences were striking: a 44% decrease in the risk of cardiovascular disease and a 21% decrease in mortality.
"These results definitely surpassed our predictions," said Dr. Genest. "We had to stop the study before its scheduled completion, as the benefit of the treatment for the selected patients was so great that we needed to present our findings to the medical community as soon as possible."
Since statins have a cholesterol-lowering effect, they are currently used to prevent cardiovascular disease in patients who are at-risk due to high LDL-c levels. But cardiovascular disease is also caused by vascular inflammation, which is marked by levels of hs-CRP. This study shows that statins indeed act on both cholesterol and inflammation, an effect that has long been suspected but not proven.
McGill University Health Centre
Cardiovascular Disease Current Events and Cardiovascular Disease News RSSNight Beat, Overtime and a Disrupted Sleep Pattern Can Harm Officers' Health
A police officer who works the night shift, typically from 8 p.m. to 4 a.m., already is at a disadvantage when it comes to getting a good "night's" sleep.
At-risk college students reduce HBP, anxiety, depression through Transcendental Meditation
The Transcendental Meditation technique may be an effective method to reduce blood pressure, anxiety, depression, and anger among at-risk college students, according to a new study to be published in the American Journal of Hypertension, December 2009.
Fat collections linked to decreased heart function
Researchers from Boston University School of Medicine (BUSM) have shown that fat collection in different body locations, such as around the heart and the aorta and within the liver, are associated with certain decreased heart functions.
Thoughtful words help couples stay fighting fit
Couples who bring thoughtful words to a fight release lower amounts of stress-related proteins, suggesting that rational communication between partners can ease the impact of marital conflict on the immune system.
Heart and bone damage from low vitamin D tied to declines in sex hormones
Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone.
New study links vitamin D deficiency to cardiovascular disease and death
While mothers have known that feeding their kids milk builds strong bones, a new study by researchers at the Heart Institute at Intermountain Medical Center in Salt Lake City suggests that Vitamin D contributes to a strong and healthy heart as well - and that inadequate levels of the vitamin may significantly increase a person's risk of stroke, heart disease, and death, even among people who've never had heart disease.
New paper describes connections between Circadian and metabolic systems
A paper by University of Notre Dame biologist Giles Duffield and a team of researchers offers new insights into a gene that plays a key role in modulating the body's Circadian system and may also simultaneously modulate its metabolic system.
Researchers 'notch' a victory toward new kind of cancer drug
Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed.
Size matters: Obesity leading risk factor of left atrial enlargement during aging
Aside from aging itself, obesity appears to be the most powerful predictor of left atrial enlargement (LAE), upping one's risk of atrial fibrillation (the most common type of arrhythmia), stroke and death.
Expectant moms, babies subjects of new Singapore study to prevent obesity and diabetes in adults
Three Singapore biomedical institutions have launched a major, long-term study of pregnant mothers and their fetuses as well as infant children to determine just how profoundly environmental factors early in life influence the onset of diseases such as obesity and diabetes in later years.
More Cardiovascular Disease Current Events and Cardiovascular Disease News Articles
 |
Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Single Volume (Heart Disease (Braunwald) (Single Vol)) by Peter Libby MD (Author), Robert O. Bonow MD (Author), Douglas L. Mann MD FACC (Author), Douglas P. Zipes MD (Author) Dr. Braunwald's masterwork returns ... bringing you the definitive guidance you need to overcome any challenge in clinical cardiology today, using the best approaches available! Hundreds of world authorities, many of them new to this edition, synthesize all of the recent developments that are revolutionizing practice - from the newest findings in molecular biology and genetics to the latest imaging modalities, interventional procedures, and medications. The expertise of the book's contributors, the scope of its coverage, and its richly illustrated, user-friendly format all make this the ultimate reference for the practicing cardiologist. Locate the answers you need fast, thanks to a user-friendly, full-color design, complete with more than 1,500 color illustrations.Glean clinically... |
 |
Reverse Heart Disease Now: Stop Deadly Cardiovascular Plaque Before It's Too Late by Sinatra (Author), James C. Roberts M.D. (Author), Martin Zucker (Contributor) While most books focus solely on the role of cholesterol in heart disease, Reverse Heart Disease Now draws on new research that points to the surprising other causes. Two leading cardiologists draw on their collective fifty years of clinical cardiology research to show you how to combine the benefits of modern medicine, over-the-counter vitamins and supplements, and simple lifestyle changes to have a healthy heart. |
|
Archives of Cardiovascular Diseases by Elsevier Masson Sas | |
|
Cardiovascular Disease:Introduction [VHS] Starring: Informed | |
 |
Understanding Cardiovascular Disease in Women Cardiovascular disease kills more American women than all forms of cancer combined, yet the perception remains that cardiovascular disease is a greater threat to men's health. This program focuses on the risks women face with cardiovascular disease, ways of reducing these risks, as well as new wide-ranging treatments for heart disease. Dr. Robert Robbins, MD, and Dr. Marcia Stefanick, Ph.D, deliver cutting-edge information on the state of research, the newest studies, and the latest treatments for cardiovascular disease in women. Dr. Robbins is the Director of the Stanford Institute for Cardiovascular Medicine. The Institute fosters and expands upon ongoing research, from the genetics and development of cardiovascular diseases to novel techniques for transplantation and restoring... |
 |
Botanic Choice Hearty Heart Bottle (Pack of 2) by Botanic Choice If you're looking for a comprehensive heart formula, look no further than Hearty Heart. This exclusive formula contains eight highly researched, well-documented, heart-supporting nutrients including policosanol, odor-controlled garlic, folic acid, CoQ-10 and more, for superior heart health. One easy-to-swallow daily capsule provides: Cayenne Pepper Powder 100 mg. - Contains free radical scavengers to help preserve the strength of arterial walls. Policosanol 10 mg. - Supports normal cholesterol already within the normal range. PureGar® Odor-Controlled Garlic 200 mg. - Helps maintain cholesterol and blood pressure already within the normal range. (min of 10,000 ppm allicin potential) Vitamin E 100 IU. - Guards against free radical damage. Folic Acid 600 mcg. - Helps... |
 |
Gary Null's Overcoming Cardiovascular Disease Naturally Starring: Ph.D. Gary Null Also With: Roland Marconi (Editor) Cardiovascular disease is not only preventable, but can be reversed and even eliminated. Find out from experts in the fields of Eastern and Western Medicine, as well as practitioners of natural healing how non-invasive therapies are used in the prevention and treatment of our nation's most deadly disease. |
 |
Lww Cardiovascular Disease 2nd Edition Anatomical Chart Laminated-9915PL1.5 by Anatomical Chart Company Lww Cardiovascular Disease 2nd Edition Anatomical Chart Laminated, This Second Edition of the Anatomical Chart Company's Cardiovascular Disease chart includes a complete update of the images and some new diseases. The chart illustrates the cardiac cycle, conduction system, and electrocardiogram (ECG) and shows anterior, posterior, and cutaway view of the heart as well as the location of coronary arteries. It also illustrates and explains the following diseases: coronary heart disease, polyarteritis nodosa (PAN), Kawasaki's disease, angina, myocardial infarction (heart attack), cerebrovascular accident (stroke), aortic aneurysm, left ventricular hypertrophy, and congestive heart failure. |
 |
Cardiovascular Disease Awareness Ribbon Mouse Pad by MyHeritageWear.com The Cardiovascular Disease Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Cardiovascular Disease Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Cardiovascular Disease Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
 |
Cardiovascular Disease and Women - DVD by Healthy Learning Cardiovascular Disease and Women - DVD Research indicates that women have unique signs and symptoms for heart disease and suggests that they may also have different risk factors for heart disease. Cardiovascular Disease and Women reviews the key factors concerning women and heart disease, including signs and symptoms, risk factors, and risk reducers. The DVD also features proven nutritional strategies that women can adopt to help reduce their risk of heart disease. Among the topics covered: CVD statistics, risk factors for heart disease, how to reduce the risk of heart disease, nutrition strategies to reduce the risk of heart disease, effect of hormone replacement therapy on CVD risk, and American Heart Association Guidelines. Produced in cooperation with the American College of Sports... |
| © 2009 BrightSurf.com |